Magnussen, HelgoLucas, Sarah JLapperre, Therese SQuint, Jennifer KDandurand, Ronald J.Roche, NicolasPapi, AlbertoPrice, DavidMiravitlles, MarcRespiratory Effectiveness Group (REG)2021-02-012021-02-012021-01-21Magnussen, H, Lucas, S J, Lapperre, T S, Quint, J K, Dandurand, R J, Roche, N, Papi, A, Price, D, Miravitlles, M & Respiratory Effectiveness Group (REG) 2021, 'Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life : Observational comparative effectiveness study', Respiratory Research, vol. 22, 25. https://doi.org/10.1186/s12931-021-01615-01465-9921https://hdl.handle.net/2164/15758FUNDING The study was funded by a grant from Boehringer Ingelheim. ACKNOWLEDGMENTS The study was designed and conducted by the Respiratory Effectiveness Group (REG; www.regresearchnetwork.org; Ely, UK) and data was delivered by Optimum Patient Care (OPC; www.optimumpatientcare.org) with support from Derek Skinner.141395410engCOPDInhaled corticosteroidsWithdrawalreal lifeeffectivenessHumansMiddle AgedAdministration, InhalationMaleTreatment OutcomeUnited Kingdom/epidemiologySafety-Based Drug Withdrawals/trendsPulmonary Disease, Chronic Obstructive/diagnosisAged, 80 and overFemaleAdrenal Cortex Hormones/administration & dosageAgedBronchodilator Agents/administration & dosageReal lifeEffectivenessR MedicineSupplementary DataRJournal article10.1186/s12931-021-01615-022